Navellier & Associates’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,348	Closed	-$601K	–	328
2022 Q1	$601K	Sell	3,348 -37	-1%	-$6.64K	0.1%	171
2021 Q4	$731K	Buy	3,385 +816	+32%	+$176K	0.11%	164
2021 Q3	$474K	Buy	+2,569	New	+$474K	0.07%	203